Sandip I Patel insider trades
Open-market stock purchases and sales by Sandip I Patel, Director at Akari Therapeutics plc, from SEC Form 4 filings since Feb 5, 2021.
Track record: 0% of 2 scored buys are up 5% or more since purchase, averaging -26%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Oct 14, 2026 | AKTX Akari Therapeutics plc | Bought (not open market) | $2 |
| Oct 14, 2026 | AKTX Akari Therapeutics plc | Bought (not open market) | $2 |
| Oct 14, 2026 | AKTX Akari Therapeutics plc | Bought (not open market) | $62.5K |
| Oct 14, 2026 | AKTX Akari Therapeutics plc | Bought (not open market) | $100K |
| Oct 5, 2026 | AKTX Akari Therapeutics plc | Bought (not open market) | $34.1K |
| Oct 1, 2026 | ATCH AtlasClear Holdings, Inc | Bought (not open market) | — |
| Sep 25, 2026 | ATCH AtlasClear Holdings, Inc | Bought (not open market) | $9.9K |
| Sep 25, 2026 | ATCH AtlasClear Holdings, Inc | Bought | $9.9K |
| Sep 24, 2026 | ATCH AtlasClear Holdings, Inc | Bought (not open market) | $10.9K |
| Sep 24, 2026 | ATCH AtlasClear Holdings, Inc | Bought | $10.9K |
| Aug 18, 2026 | AKTX Akari Therapeutics plc | Bought (not open market) | $95.6K |
| Aug 18, 2026 | AKTX Akari Therapeutics plc | Bought (not open market) | — |
| Aug 18, 2026 | AKTX Akari Therapeutics plc | Bought (not open market) | — |
| Jul 14, 2026 | ATCH AtlasClear Holdings, Inc | Bought (not open market) | — |
| Jul 14, 2026 | ATCH AtlasClear Holdings, Inc | Bought (not open market) | — |
| Dec 16, 2025 | AKTX Akari Therapeutics plc | Bought | $62.5K |
| Dec 16, 2025 | AKTX Akari Therapeutics plc | Bought | $100K |
Companies traded
- AKTX Akari Therapeutics plc: 2 buys, last Oct 14, 2026
- ATCH AtlasClear Holdings, Inc: 2 buys, last Oct 1, 2026
- PKBO Peak Bio, Inc: other filings, last Nov 14, 2024
- QFTA Quantum FinTech Acquisition Corp: other filings, last Feb 9, 2024
- MTRY Monterey Innovation Acquisition Corp: 1 sale, last Mar 9, 2023
- QFTA.U Quantum FinTech Acquisition Corp: 1 buy, last Feb 5, 2021